Ilixadencel granted Regenerative Medicine Advanced Therapy by FDA for metastatic kidney cancer
The US Food and Drug Administration (FDA) has designated ilixadencel [...]
Avelumab plus axitinib combination shows promise
A clinical trial looking at the combination of avelumab plus [...]
Avelumab combination designated a breakthrough therapy by the FDA
The immunotherapy drug avelumab (Bavencio) has been designated a breakthrough [...]
